{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:33:16Z","timestamp":1783441996235,"version":"3.54.6"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2025B1515020010"],"award-info":[{"award-number":["2025B1515020010"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022B1515020075"],"award-info":[{"award-number":["2022B1515020075"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515110907"],"award-info":[{"award-number":["2023A1515110907"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371846"],"award-info":[{"award-number":["82371846"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jconrel.2025.114339","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T19:57:10Z","timestamp":1760731030000},"page":"114339","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"P1","title":["A multivalent nanoparticle vaccine elicits potent neutralizing antibody response against monkeypox virus"],"prefix":"10.1016","volume":"388","author":[{"given":"Run-Yu","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Bing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Guang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Feng","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.114339_bb0005","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41577-022-00775-4","article-title":"Monkeypox: disease epidemiology, host immunity and clinical interventions","volume":"22","author":"Lum","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.114339_bb0010","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/s41564-024-01690-1","article-title":"Understanding the biology of monkeypox virus to prevent future outbreaks","volume":"9","author":"Moss","year":"2024","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.jconrel.2025.114339_bb0015","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1126\/science.add2701","article-title":"Global outbreak puts spotlight on neglected virus","volume":"376","author":"Cohen","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2025.114339_bb0020","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1056\/NEJMoa2207323","article-title":"Monkeypox virus infection in humans across 16 Countries - April-June 2022","volume":"vol. 387","author":"Thornhill","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2025.114339_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2023.106156","article-title":"Progress and prospects on vaccine development against monkeypox infection","volume":"180","author":"Saadh","year":"2023","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.jconrel.2025.114339_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.06.021","article-title":"Vaccine effectiveness of 3rd generation mpox vaccines against mpox and disease severity: a systematic review and meta-analysis","volume":"42","author":"Pischel","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2025.114339_bb0035","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41591-022-02090-w","article-title":"Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals","volume":"29","author":"Zaeck","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2025.114339_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105392","article-title":"Single-chain A35R-M1R-B6R trivalent mRNA vaccines protect mice against both mpox virus and vaccinia virus","volume":"109","author":"Kong","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jconrel.2025.114339_bb0045","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41541-022-00527-4","article-title":"Current status of monkeypox vaccines","volume":"7","author":"Gruber","year":"2022","journal-title":"NPJ Vaccines"},{"issue":"2022","key":"10.1016\/j.jconrel.2025.114339_bb0050","doi-asserted-by":"crossref","first-page":"734","DOI":"10.15585\/mmwr.mm7122e1","article-title":"Use of JYNNEOS (smallpox and Monkeypox vaccine, live, nonreplicating) for Preexposure vaccination of persons at risk for occupational exposure to Orthopoxviruses: recommendations of the advisory committee on immunization practices - United States","volume":"71","author":"Rao","year":"2022","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"key":"10.1016\/j.jconrel.2025.114339_bb0055","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1600-065X.2010.00975.x","article-title":"Smallpox vaccines: targets of protective immunity","volume":"239","author":"Moss","year":"2011","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jconrel.2025.114339_bb0060","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nm1273","article-title":"Multiple diagnostic techniques identify previously vaccinated individuals with protective immunity against monkeypox","volume":"11","author":"Hammarlund","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2025.114339_bb0065","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1128\/JVI.80.5.2127-2140.2006","article-title":"Vaccinia virus proteome: identification of proteins in vaccinia virus intracellular mature virion particles","volume":"80","author":"Chung","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2025.114339_bb0070","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1743-422X-3-10","article-title":"Pox proteomics: mass spectrometry analysis and identification of vaccinia virion proteins","volume":"3","author":"Yoder","year":"2006","journal-title":"Virol. J."},{"key":"10.1016\/j.jconrel.2025.114339_bb0075","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.virol.2006.08.025","article-title":"Protein composition of the vaccinia virus mature virion","volume":"358","author":"Resch","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.jconrel.2025.114339_bb0080","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.cell.2016.09.049","article-title":"Cross-neutralizing and protective human antibody specificities to poxvirus infections","volume":"167","author":"Gilchuk","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2025.114339_bb0085","doi-asserted-by":"crossref","first-page":"10230","DOI":"10.1128\/JVI.78.19.10230-10237.2004","article-title":"Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions","volume":"78","author":"Fogg","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2025.114339_bb0090","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1006\/viro.1999.0096","article-title":"DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge","volume":"266","author":"Hooper","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.jconrel.2025.114339_bb0095","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0042-6822(02)00038-7","article-title":"Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates","volume":"306","author":"Hooper","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.jconrel.2025.114339_bb0100","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1128\/JVI.78.9.4433-4443.2004","article-title":"Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox","volume":"78","author":"Hooper","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2025.114339_bb0105","doi-asserted-by":"crossref","first-page":"eadg3540","DOI":"10.1126\/scitranslmed.adg3540","article-title":"An mpox virus mRNA-lipid nanoparticle vaccine confers protection against lethal orthopoxviral challenge","volume":"15","author":"Freyn","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.114339_bb0110","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1038\/s41467-023-41628-5","article-title":"mRNA vaccines encoding fusion proteins of monkeypox virus antigens protect mice from vaccinia virus challenge","volume":"14","author":"Hou","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114339_bb0115","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41590-023-01715-7","article-title":"Rational design of a \u2018two-in-one\u2019 immunogen DAM drives potent immune response against mpox virus","volume":"25","author":"Wang","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2025.114339_bb0120","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.ymthe.2024.04.028","article-title":"Circular RNA vaccines against monkeypox virus provide potent protection against vaccinia virus infection in mice","volume":"32","author":"Zhou","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2025.114339_bb0125","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.cell.2024.01.017","article-title":"A multivalent mRNA monkeypox virus vaccine (BNT166) protects mice and macaques from orthopoxvirus disease","volume":"187","author":"Zuiani","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2025.114339_bb0130","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","article-title":"mRNA vaccines for infectious diseases: principles, delivery and clinical translation","volume":"20","author":"Chaudhary","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2025.114339_bb0135","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S0140-6736(23)02444-3","article-title":"mRNA-based therapeutics: looking beyond COVID-19 vaccines","volume":"403","author":"Parhiz","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2025.114339_bb0140","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41571-024-00902-1","article-title":"Cancer mRNA vaccines: clinical advances and future opportunities","volume":"21","author":"Sayour","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2025.114339_bb0145","doi-asserted-by":"crossref","first-page":"5540","DOI":"10.1016\/j.cell.2024.08.043","article-title":"Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhuman primates","volume":"187","author":"Mucker","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2025.114339_bb0150","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.cell.2020.10.043","article-title":"Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2","volume":"183","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2025.114339_bb0155","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41541-023-00622-0","article-title":"Immunogenicity and protective efficacy of GBP510\/AS03 vaccine against SARS-CoV-2 delta challenge in rhesus macaques","volume":"8","author":"Jacob-Dolan","year":"2023","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.jconrel.2025.114339_bb0160","doi-asserted-by":"crossref","first-page":"102140","DOI":"10.1016\/j.eclinm.2023.102140","article-title":"Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03: interim results of a randomised, active-controlled, observer-blinded, phase 3 trial","volume":"64","author":"Song","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jconrel.2025.114339_bb0165","doi-asserted-by":"crossref","first-page":"2412640","DOI":"10.1080\/22221751.2024.2412640","article-title":"TianTan vaccinia virus-based EBV vaccines targeting both latent and lytic antigens elicits potent immunity against lethal EBV challenge in humanized mice","volume":"13","author":"Zhang","year":"2024","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.jconrel.2025.114339_bb0170","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41421-024-00739-z","article-title":"Pathogenic BALB\/c mice infection model for evaluation of mpox countermeasures","volume":"10","author":"Cheng","year":"2024","journal-title":"Cell Discov."},{"key":"10.1016\/j.jconrel.2025.114339_bb0175","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1038\/s41467-024-48754-8","article-title":"Longitudinal viral shedding and antibody response characteristics of men with acute infection of monkeypox virus: a prospective cohort study","volume":"15","author":"Yang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114339_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116358","article-title":"A single-dose nanoparticle vaccine protects against mpox in preclinical models","volume":"44","author":"Yuan","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2025.114339_bb0185","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/s41590-024-01776-2","article-title":"The receptor binding domain of SARS-CoV-2 omicron subvariants targets Siglec-9 to decrease its immunogenicity by preventing macrophage phagocytosis","volume":"25","author":"He","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2025.114339_bb0190","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1021\/acsnano.0c08379","article-title":"Rapid development of SARS-CoV-2 spike protein receptor-binding domain self-assembled nanoparticle vaccine candidates","volume":"15","author":"Kang","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114339_bb0195","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0022-1759(90)90029-U","article-title":"Removal of endotoxin from protein solutions by phase separation using Triton X-114","volume":"132","author":"Aida","year":"1990","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jconrel.2025.114339_bb0200","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1038\/s41467-022-30222-w","article-title":"Quadrivalent mosaic HexaPro-bearing nanoparticle vaccine protects against infection of SARS-CoV-2 variants","volume":"13","author":"Kang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114339_bb0205","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abg1143","article-title":"A recombinant spike protein subunit vaccine confers protective immunity against SARS-CoV-2 infection and transmission in hamsters","volume":"13","author":"Wu","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.114339_bb0210","article-title":"Development of a PCSK9-targeted nanoparticle vaccine to effectively decrease the hypercholesterolemia","volume":"5","author":"Fang","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.jconrel.2025.114339_bb0215","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1128\/JVI.01797-08","article-title":"Vaccinia virus extracellular enveloped virion neutralization in vitro and protection in vivo depend on complement","volume":"83","author":"Benhnia","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2025.114339_bb0220","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.chom.2023.05.001","article-title":"Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individuals","volume":"31","author":"Hubert","year":"2023","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jconrel.2025.114339_bb0225","doi-asserted-by":"crossref","first-page":"2401931","DOI":"10.1080\/22221751.2024.2401931","article-title":"Identification of mpox M1R and B6R monoclonal and bispecific antibodies that efficiently neutralize authentic mpox virus","volume":"13","author":"Ren","year":"2024","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.jconrel.2025.114339_bb0230","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.virol.2007.06.042","article-title":"Structural basis for the binding of the neutralizing antibody, 7D11, to the poxvirus L1 protein","volume":"368","author":"Su","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.jconrel.2025.114339_bb0235","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/s41589-023-01529-6","article-title":"Vaccine design via antigen reorientation","volume":"20","author":"Xu","year":"2024","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jconrel.2025.114339_bb0240","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nm1261","article-title":"Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus","volume":"11","author":"Edghill-Smith","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2025.114339_bb0245","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nri2644","article-title":"New insights into the differentiation and function of T follicular helper cells","volume":"9","author":"King","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.114339_bb0250","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.immuni.2016.09.001","article-title":"Germinal center B cell dynamics","volume":"45","author":"Mesin","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2025.114339_bb0255","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.tips.2022.10.005","article-title":"Monkeypox: potential vaccine development strategies","volume":"44","author":"Lozano","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jconrel.2025.114339_bb0260","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41577-020-00480-0","article-title":"Viral targets for vaccines against COVID-19","volume":"21","author":"Dai","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.114339_bb0265","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/s41565-022-01129-w","article-title":"Characterization of nanoparticles-based vaccines for COVID-19","volume":"17","author":"Guerrini","year":"2022","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2025.114339_bb0270","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41565-020-00790-3","article-title":"Eliciting B cell immunity against infectious diseases using nanovaccines","volume":"16","author":"Singh","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2025.114339_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2023.105668","article-title":"Mpox virus mRNA-lipid nanoparticle vaccine candidates evoke antibody responses and drive protection against the vaccinia virus challenge in mice","volume":"216","author":"Xia","year":"2023","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jconrel.2025.114339_bb0280","doi-asserted-by":"crossref","first-page":"2204151","DOI":"10.1080\/22221751.2023.2204151","article-title":"Mpox multi-antigen mRNA vaccine candidates by a simplified manufacturing strategy afford efficient protection against lethal orthopoxvirus challenge","volume":"12","author":"Zeng","year":"2023","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.jconrel.2025.114339_bb0285","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1007\/s11427-023-2378-x","article-title":"Multi-valent mRNA vaccines against monkeypox enveloped or mature viron surface antigens demonstrate robust immune response and neutralizing activity","volume":"66","author":"Zhang","year":"2023","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.jconrel.2025.114339_bb0290","doi-asserted-by":"crossref","first-page":"2192815","DOI":"10.1080\/22221751.2023.2192815","article-title":"Rational development of multicomponent mRNA vaccine candidates against mpox","volume":"12","author":"Zhang","year":"2023","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.jconrel.2025.114339_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114269","article-title":"Polyvalent mpox mRNA vaccines elicit robust immune responses and confer potent protection against vaccinia virus","volume":"43","author":"Ye","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2025.114339_bb0300","doi-asserted-by":"crossref","first-page":"2535485","DOI":"10.1080\/22221751.2025.2535485","article-title":"A bivalent Mpox nanoparticle vaccine induces robust immune response and provides long-lasting protection against vaccinia virus challenge","volume":"14","author":"Wang","year":"2025","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.jconrel.2025.114339_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1013389","article-title":"Multivalent mpox protein nanoparticle vaccines confer cross-protection against orthopoxvirus infection","volume":"21","author":"Zhang","year":"2025","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jconrel.2025.114339_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104424","article-title":"The land-scape of immune response to monkeypox virus","volume":"87","author":"Li","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jconrel.2025.114339_bb0315","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.1016\/j.vaccine.2010.07.030","article-title":"A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge","volume":"28","author":"Buchman","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2025.114339_bb0320","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.4049\/jimmunol.177.4.2552","article-title":"Subunit recombinant vaccine protects against monkeypox","volume":"177","author":"Heraud","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2025.114339_bb0325","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1016\/j.vaccine.2008.04.017","article-title":"Targeting the vaccinia virus L1 protein to the cell surface enhances production of neutralizing antibodies","volume":"26","author":"Golden","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2025.114339_bb0330","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2025.114339_bb0335","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41392-023-01432-5","article-title":"Monkeypox virus quadrivalent mRNA vaccine induces immune response and protects against vaccinia virus","volume":"8","author":"Sang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2025.114339_bb0340","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/s41586-021-03530-2","article-title":"Adjuvanting a subunit COVID-19 vaccine to induce protective immunity","volume":"594","author":"Arunachalam","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.114339_bb0345","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1016\/j.immuni.2022.10.015","article-title":"Co-immunization with hemagglutinin stem immunogens elicits cross-group neutralizing antibodies and broad protection against influenza A viruses","volume":"55","author":"Moin","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2025.114339_bb0350","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1126\/science.aat9120","article-title":"Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centers","volume":"363","author":"Tokatlian","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2025.114339_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127598","article-title":"Current and emerging Mpox vaccine strategies: a comprehensive review","volume":"62","author":"Ortiz-Prado","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2025.114339_bb0360","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1080\/14760584.2024.2397006","article-title":"Vaccines against mpox: MVA-BN and LC16m8","volume":"23","author":"Grabenstein","year":"2024","journal-title":"Expert Rev. Vaccines"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925009538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925009538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T14:11:40Z","timestamp":1769868700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925009538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":72,"alternative-id":["S0168365925009538"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114339","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A multivalent nanoparticle vaccine elicits potent neutralizing antibody response against monkeypox virus","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114339","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114339"}}